Relevium Technologies Inc.


By |

Investing in Active Lifestyles & Healthy Living

Relevium is a publicly traded corporation strategically focused in musculoskeletal function specifically in the areas of pain relief, recovery and performance enhancement.

The company’s first acquisition is a patented technology that helps the recovery process from musculoskeletal injuries. Musculoskeletal injuries and dysfunction represent a major source of economic burden on the medical systems of most developed countries. Musculoskeletal conditions are also a major cause of absence from work comprising the majority of all work-related illness.

Through its wholly-owned subsidiary Bioflex Technologies Inc., the company will focus on the development and commercialization of magnetic therapeutic devices to assist in the recovery and healing process from injuries in muscles, ligaments, tendons and nerves.

Our Focus

Pain Relief
pain relief



Pain avoidance is one of the most important drivers of consumer behavior worldwide. Pain relief currently represents a $31 billion market and expected to grow at a CAGR of 5% every year. The primary focus of Relevium in this vertical segment is on wearable devices that reduce musculoskeletal pain caused by injuries or mechanical dysfunction.

Musculoskeletal injuries such as sprains and strains are amongst the most common and costly burdens to the medical system and workforce. Direct and indirect costs are said to exceed $150 billion per year in Canada and the US alone. The primary focus of Relevium in this vertical segment is on wearable technologies that reduce recovery times in treating musculoskeletal injuries.

The global sports apparel market was worth over $135 billion in 2012. Growing fitness consciousness, rising income levels in developing countries and increasing popularity of sports apparel is expected to drive market growth at a CAGR of 4% per year. The primary focus of Relevium in this vertical segment is on wearable technologies that enhance athletic performance and reduce recovery time.

For more information please visit

Additional Material

Relevium Technologies Inc.


Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Contact Information

Main Phone: +1 514 562-1374
Address: 3733 Cote Vertu
Address 2: Suite 350
State: QC
City / Town: Saint-Laurent
Country: CAN
Postal Code: H4R 2M3

Issuer Information

Exchange: CDX
CEO: Leena Lakdawala
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Ophthalmic Goods
$ 0.05 $ 0. (0.00%)
Last Price 0.05 Change $ 0. Change % 0.00 Tick N/A
Bid 0.065 Bid Size 60,000.00 Ask 0.065 Ask Size 8,000.00
Open N/A High N/A Low N/A Prev Close 0.05
Last Trade Volume 0 52 Wk Hi 0.15 52 Wk Low 0.04
Market Cap 1.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 34,583,966.00 EPS (TTM) -0.05 PE Ratio N/A Exchange TSXV